TY - JOUR AU - Zhang, Binglei AU - Zhou, Jian AU - Yu, Fengkuan AU - Lv, Tianxin AU - Fang, Baijun AU - Fan, Dandan AU - Ji, Zhenyu AU - Song, Yongping PY - 2020 DA - 2020/04/06 TI - Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial JO - Experimental Hematology & Oncology SP - 5 VL - 9 IS - 1 AB - The high-risk refractory and/or relapsed (R/R) childhood acute leukemia prognosis is poor, and allogeneic stem cell transplantation (allo-HSCT) is the most prudent treatment modality. However, there are limited matched sibling donors (MSDs), and alternative donors (ADs) are the main source for allo-HSCT. Thus, we evaluated the clinical efficacy of AD peripheral allo-HSCT for treating high-risk R/R childhood acute leukemia. SN - 2162-3619 UR - https://doi.org/10.1186/s40164-020-00162-6 DO - 10.1186/s40164-020-00162-6 ID - Zhang2020 ER -